What is Isomorphic Labs?
Isomorphic Labs is a drug-discovery company spun out of Google DeepMind, led by Demis Hassabis, that builds on the protein-structure prediction breakthroughs of AlphaFold. It raised $2.1 billion in May 2026 in one of the largest funding rounds in AI drug discovery to date.
Answered in
Hassabis Left DeepMind's Day-to-Day to Build the Drug Engine Beyond AlphaFoldDemis Hassabis stepped back from running DeepMind to lead Isomorphic Labs full-time, where a $2.1 billion bet is turning AlphaFold into actual drugs.
Read the full analysisOther questions this article answers
More how ai actually works questions
- What does Google's Deep Review accept?
- Did the Paper Assistant Tool replace conference peer review?
- Are uploaded documents used to train Google models?
- When does Google Workspace begin enforcing the MCP OAuth client marker?
- Will this change break regular Google Workspace REST API integrations?
- What should a team do if one OAuth client serves agents and regular integrations?
- What is NVIDIA Dory 1.0?
- Does increasing Dory's loop count make it a larger model?
Every answer on Crashtech is written by the editor of the article it comes from — never auto-summarised. Browse all answers or the How AI Actually Works beat.